| Authors: |
Ardeshir M; Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran., Rafiemanesh H; Non-communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran., Rostam-Abadi Y; Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran.; Department of Psychiatry, Yale University, New Haven, CT, USA., Gholami J; Edith Collins Centre, Translational Research for Alcohol, Drugs and Toxicology, Royal Prince Alfred Hospital, Camperdown, Australia., Amin-Esmaeili M; Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran.; Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Baheshmat S; Department of Neuroscience and Addiction Studies, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran., Hamzehzadeh M; Department of Neuroscience and Addiction Studies, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran., Farahmand K; Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran., Mohammad Aghaei A; Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran., Safarcherati A; Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran., Rahimi-Movaghar A; Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran. |
